Find investors
← Back to all investors
Gail Boudreaux
ResearchedAngel Investors

Gail Boudreaux

President, Chief Executive Officer & Board Member

Angel InvestorsSeed Round
Pitch Gail

Get their honest, personalized take on your startup.

Sign in to pitch Gail

At a glance

Full Name
Gail Koziara Boudreaux
Title
President, Chief Executive Officer & Board Member, Elevance Health, Inc.
Firm
Elevance Health (formerly Anthem, Inc.)
Firm Type
Fortune 100 public healthcare / health-insurance company (NYSE: ELV) — *not, based on available public record, an angel-investment vehicle*
Investment Stage
No public record of active seed/angel startup investing (see note below)
Check Size
Not publicly documented
Target Company Profile
Not publicly documented
Sector Focus
Healthcare, health insurance, and healthcare services (Carelon)
Geographic Focus
United States
Location
Indianapolis, Indiana, USA

Background

Gail Koziara Boudreaux (born 1960 in Chicopee, Massachusetts) is President and CEO of Elevance Health, the Indianapolis-based health company formerly known as Anthem. She earned a B.A. in psychology (cum laude) from Dartmouth College in 1982 and an MBA (with high honors) from Columbia University in 1989. At Dartmouth she was a standout athlete — a three-time Ivy League Player of the Year in women's basketball, the school's all-time leading scorer and rebounder, and a four-time Ivy League shot-put champion — and is a member of the New England Basketball Hall of Fame.

Her healthcare career spans more than 30 years. She spent roughly two decades at Aetna in executive insurance roles, then became president of Blue Cross and Blue Shield of Illinois (2002) and executive vice president for external operations at parent Health Care Service Corporation (HCSC). In 2008 she joined UnitedHealth Group as EVP, and from 2011 to 2014 served as CEO of UnitedHealthcare, then the largest U.S. health insurer with roughly 45 million members. In 2015 she founded and ran her own healthcare-strategy consultancy, GKB Global Health, LLC.

In November 2017 she was named CEO of Anthem, Inc., which rebranded as Elevance Health in 2022. She now leads more than 100,000 associates serving over 110 million people, with 2024 revenue of about $175 billion. She has been ranked among Forbes' "World's 100 Most Powerful Women" (No. 10 in 2020, No. 14 in 2023) and Fortune's Most Powerful Women, and in 2023 became the first woman elected chair of The Business Council. She also serves on the board of directors of Target Corporation.

Investment Thesis & Focus

  • No publicly stated angel/venture investment thesis exists for Ms. Boudreaux; the framing of her as a seed-stage angel investor is not supported by available sources.
  • Her professional "focus," insofar as capital allocation goes, is corporate — Elevance Health's strategy of "simple, affordable, and accessible healthcare," expansion of its Carelon health-services segment, and value-based care.
  • Her documented personal investments are concentrated in large-cap healthcare equities (notably Elevance Health and UnitedHealth Group holdings accrued through her executive roles), consistent with an operator/executive rather than a startup financier.

Notable Investments

  • No documented startup / angel portfolio. Public filings and reporting show substantial personal equity in UnitedHealth Group and Elevance Health (executive compensation and legacy holdings), plus smaller disclosed stakes in names such as Zimmer Biomet, Xcel Energy, and Novavax — these are public-market holdings, not private/angel deals.
  • If startup investing is the intended profile use-case, this record could not be verified from public sources and should be confirmed directly before relying on it.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.